Chakradhar, Anjali
Baron, Rebecca M.
Vera, Mayra Pinilla
Devarajan, Prasad
Chawla, Lakhmir
Hou, Peter C.
Article History
Received: 12 April 2023
Accepted: 13 March 2024
First Online: 20 March 2024
Competing interests
: PCH reports grant/contract payments made to his institution from CalciMedica, National Institute of Health, US Department of Defense, US Center for Disease Control, Good Ventures, Rapid Pathogen Screening, Novartis, Kinevant Sciences GmbH, Mesoblast, Ophirex, Inc., Faron Pharmaceuticals, Day Zero Diagnostics, and iDoc Telehealth Solutions. RMB is on the advisory boards for Merck and Genentech. PD is a co-inventor on patents for the use of NGAL as a biomarker of kidney injury.